|
|
|
Volumn 83, Issue 6, 1998, Pages 481-482
|
|
Secondary or therapy-related MDS and AML and their chromosome aberrations: Important to study but difficult to establish causality
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
GYRASE INHIBITOR;
ACUTE GRANULOCYTIC LEUKEMIA;
CANCER;
CANCER CHEMOTHERAPY;
CANCER RISK;
CHROMOSOME ABERRATION;
DIFFERENTIAL DIAGNOSIS;
DRUG INDUCED DISEASE;
EDITORIAL;
HUMAN;
LEUKEMOGENESIS;
MYELODYSPLASTIC SYNDROME;
RISK FACTOR;
SECOND CANCER;
ACUTE DISEASE;
CHROMOSOME ABERRATIONS;
DRUG THERAPY;
HUMANS;
LEUKEMIA, MYELOID;
MYELODYSPLASTIC SYNDROMES;
|
|
EID: 0031820546
PISSN: 03906078
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (20)
|
|
References (19)
|
